glp-1 and ckd CKJ REVIEW receptor agonists in patients with chronic kidney disease either overweight or obesit The privileged position of glp-1

doi: 10.3390/app15052658 171

According to the International Diabetes Federation (IDF), about 537 million people worldwide have diabetes, with 90% being T2D

Some supplements can interfere with your thyroid function or medication effectiveness, potentially complicating the management of these conditions

L-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis

The peptide also shows potential DHT protection through copper ions inhibiting up to 90% of type 1 5-alpha reductase at specific concentrations, which targets the enzyme most involved in hair follicle miniaturization

However, this boost was temporary, returning to baseline levels after a period without coffee consumption